Matches in SemOpenAlex for { <https://semopenalex.org/work/W2319080641> ?p ?o ?g. }
- W2319080641 endingPage "16" @default.
- W2319080641 startingPage "11" @default.
- W2319080641 abstract "PurposeThe aim of this study was to compare the risk of metabolic syndrome (MS) and evaluate related factors for MS among people with epilepsy treated with valproate (VPA) or carbamazepine (CBZ).MethodsA total of 213 adult patients with epilepsy treated with VPA (n = 118) or CBZ (n = 95) monotherapy were included in the study. Participants were evaluated for the presence of MS, diagnosed according to the National Cholesterol Education Program Adult Treatment Panel III criteria.ResultsIn the multiple logistic regression analysis, the risk of MS in CBZ- and VPA-treated patients was similar (odds ratio [OR] = 0.99; 95% confidence interval [CI], 0.43–2.26; P = 0.979). A lower proportion of CBZ-treated patients had abnormally low levels of high-density lipoprotein cholesterol (OR = 0.10; 95% CI, 0.02–0.42; P = 0.002), whereas a lower proportion of VPA-treated patients had abnormally high concentrations of fasting blood glucose (OR = 0.30; 95% CI, 0.13–0.69; P = 0.004). Females treated with VPA tended to have a higher risk of MS (OR = 1.48; 95% CI, 0.50–4.41; P = 0.485) compared to males (OR = 0.74; 95% CI, 0.28–1.96; P = 0.551), although this difference was not statistically significant.ConclusionAlthough the overall risk of MS was similar in patients with epilepsy who were treated with VPA or CBZ, the distribution of MS components differed between treatment groups. Patients treated with CBZ or VPA less frequently had decreased high-density lipoprotein cholesterol levels or increased blood glucose concentrations, respectively. Females on VPA treatment could be at higher risk of MS than males." @default.
- W2319080641 created "2016-06-24" @default.
- W2319080641 creator A5008870216 @default.
- W2319080641 creator A5010137871 @default.
- W2319080641 creator A5037656140 @default.
- W2319080641 date "2016-05-01" @default.
- W2319080641 modified "2023-10-18" @default.
- W2319080641 title "Metabolic syndrome and anticonvulsants: A comparative study of valproic acid and carbamazepine" @default.
- W2319080641 cites W1480991552 @default.
- W2319080641 cites W1563486146 @default.
- W2319080641 cites W1593901930 @default.
- W2319080641 cites W1798753198 @default.
- W2319080641 cites W1954224626 @default.
- W2319080641 cites W1965500568 @default.
- W2319080641 cites W1966945491 @default.
- W2319080641 cites W1972806650 @default.
- W2319080641 cites W1984441824 @default.
- W2319080641 cites W1989337793 @default.
- W2319080641 cites W1991821311 @default.
- W2319080641 cites W2010206716 @default.
- W2319080641 cites W2013796718 @default.
- W2319080641 cites W2018561342 @default.
- W2319080641 cites W2025365102 @default.
- W2319080641 cites W2035091931 @default.
- W2319080641 cites W2038157135 @default.
- W2319080641 cites W2044133052 @default.
- W2319080641 cites W2051163013 @default.
- W2319080641 cites W2061784543 @default.
- W2319080641 cites W2069521313 @default.
- W2319080641 cites W2069641340 @default.
- W2319080641 cites W2072305189 @default.
- W2319080641 cites W2077008944 @default.
- W2319080641 cites W2077666970 @default.
- W2319080641 cites W2091848745 @default.
- W2319080641 cites W2096773810 @default.
- W2319080641 cites W2099478180 @default.
- W2319080641 cites W2126661869 @default.
- W2319080641 cites W2139254676 @default.
- W2319080641 cites W2147561038 @default.
- W2319080641 cites W2155216463 @default.
- W2319080641 cites W2157974034 @default.
- W2319080641 cites W2164724677 @default.
- W2319080641 cites W2322086287 @default.
- W2319080641 cites W2596500039 @default.
- W2319080641 cites W4210956151 @default.
- W2319080641 doi "https://doi.org/10.1016/j.seizure.2016.03.008" @default.
- W2319080641 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27061880" @default.
- W2319080641 hasPublicationYear "2016" @default.
- W2319080641 type Work @default.
- W2319080641 sameAs 2319080641 @default.
- W2319080641 citedByCount "17" @default.
- W2319080641 countsByYear W23190806412016 @default.
- W2319080641 countsByYear W23190806412017 @default.
- W2319080641 countsByYear W23190806412018 @default.
- W2319080641 countsByYear W23190806412020 @default.
- W2319080641 countsByYear W23190806412021 @default.
- W2319080641 countsByYear W23190806412022 @default.
- W2319080641 countsByYear W23190806412023 @default.
- W2319080641 crossrefType "journal-article" @default.
- W2319080641 hasAuthorship W2319080641A5008870216 @default.
- W2319080641 hasAuthorship W2319080641A5010137871 @default.
- W2319080641 hasAuthorship W2319080641A5037656140 @default.
- W2319080641 hasBestOaLocation W23190806411 @default.
- W2319080641 hasConcept C118552586 @default.
- W2319080641 hasConcept C126322002 @default.
- W2319080641 hasConcept C134018914 @default.
- W2319080641 hasConcept C151956035 @default.
- W2319080641 hasConcept C156957248 @default.
- W2319080641 hasConcept C2775858608 @default.
- W2319080641 hasConcept C2777172819 @default.
- W2319080641 hasConcept C2778186239 @default.
- W2319080641 hasConcept C2778402494 @default.
- W2319080641 hasConcept C2779253243 @default.
- W2319080641 hasConcept C2780578515 @default.
- W2319080641 hasConcept C44249647 @default.
- W2319080641 hasConcept C511355011 @default.
- W2319080641 hasConcept C71924100 @default.
- W2319080641 hasConcept C90924648 @default.
- W2319080641 hasConceptScore W2319080641C118552586 @default.
- W2319080641 hasConceptScore W2319080641C126322002 @default.
- W2319080641 hasConceptScore W2319080641C134018914 @default.
- W2319080641 hasConceptScore W2319080641C151956035 @default.
- W2319080641 hasConceptScore W2319080641C156957248 @default.
- W2319080641 hasConceptScore W2319080641C2775858608 @default.
- W2319080641 hasConceptScore W2319080641C2777172819 @default.
- W2319080641 hasConceptScore W2319080641C2778186239 @default.
- W2319080641 hasConceptScore W2319080641C2778402494 @default.
- W2319080641 hasConceptScore W2319080641C2779253243 @default.
- W2319080641 hasConceptScore W2319080641C2780578515 @default.
- W2319080641 hasConceptScore W2319080641C44249647 @default.
- W2319080641 hasConceptScore W2319080641C511355011 @default.
- W2319080641 hasConceptScore W2319080641C71924100 @default.
- W2319080641 hasConceptScore W2319080641C90924648 @default.
- W2319080641 hasFunder F4320321018 @default.
- W2319080641 hasLocation W23190806411 @default.
- W2319080641 hasLocation W23190806412 @default.
- W2319080641 hasOpenAccess W2319080641 @default.
- W2319080641 hasPrimaryLocation W23190806411 @default.